Halo-substituted bisindolemaleimide protein kinase C inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514183, 514185, 514410, 540450, 540456, 540467, 540472, 640480, 640474, C07D26900, C07D41314, A61K 3155, A61K 31395

Patent

active

059360844

ABSTRACT:
The present invention is directed to novel halo-substituted bis-indolemaleimide compounds of the formula: ##STR1## The invention further provides a method of preparing the disclosed compounds and the preparation of pharmaceutical formulation for use in inhibiting Protein Kinase C in mammals.

REFERENCES:
patent: 5380746 (1995-01-01), Barth et al.
patent: 5438050 (1995-08-01), Kleinschroth et al.
patent: 5516915 (1996-05-01), Barth et al.
patent: 5552396 (1996-09-01), Heath et al.
patent: 5559228 (1996-09-01), Heath et al.
patent: 5589472 (1996-12-01), Vice
patent: 5621098 (1997-04-01), Heath, Jr. et al.
patent: 5624108 (1997-04-01), Heath et al.
patent: 5696949 (1997-12-01), Heath et al.
"A Short Synthesis of 2-Deoxy-2-fluoro-ribo-D-pentopyranose", Welch et al., J. Chem. Soc., Chem. Commun., pp. 186-188, 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Halo-substituted bisindolemaleimide protein kinase C inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Halo-substituted bisindolemaleimide protein kinase C inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halo-substituted bisindolemaleimide protein kinase C inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1121297

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.